1. An industry perspective: importance of organs-on-chips for advancing drug discovery and development. (September 2021) Authors: Roth, A.B. Journal: Toxicology letters Issue: Volume 350(2021)Supplement Page Start: S36 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Minimizing DILI risk in drug discovery — A screening tool for drug candidates. Issue 1 (25th December 2015) Authors: Schadt, S.; Simon, S.; Kustermann, S.; Boess, F.; McGinnis, C.; Brink, A.; Lieven, R.; Fowler, S.; Youdim, K.; Ullah, M.; Marschmann, M.; Zihlmann, C.; Siegrist, Y.M.; Cascais, A.C.; Di Lenarda, E.; Durr, E.; Schaub, N.; Ang, X.; Starke, V.; Singer, T. Journal: Toxicology in vitro Issue: Volume 30:Issue 1 Part B(2015) Page Start: 429 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Safety and efficacy profiling of T-cell bispecific antibodies using the intestine-chip. (10th October 2018) Authors: Kerns, S.J.; Obrigewitch, J.; Roth, A.B.; Karalis, K.; Salmon, M.; Hamilton, G.A.; Moisan, A. Journal: Toxicology letters Issue: Volume 295(2018) Page Start: S130 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗